👏 New study from Dávid Tornai and colleagues 🎉: Serum #Villin1 is a promising non-invasive marker of #GutBarrier damage in #cirrhosis and #ACLF.
It rises with severity, predicts 90-day mortality, links to #inflammation, and has been validated in an independent cohort!
📜 doi.org/10.1111/apt....
5
2
1
0